OtisMed, Ex-CEO Cop To Distributing Device After FDA Denial
Law360, New York (December 8, 2014, 6:51 PM EST) -- Stryker Corp.'s OtisMed unit will pay more than $80 million to resolve criminal and civil claims in New Jersey that it distributed knee replacement surgery devices without proper federal clearance — allegations that have also led to the guilty plea of OtisMed's former chief executive officer, prosecutors announced Monday.
U.S. Attorney for the District of New Jersey Paul Fishman and other federal officials announced the guilty pleas of OtisMed and former CEO Charlie Chi over the intentional shipping of OtisKnee orthopedic cutting guides in September 2009 after the U.S. Food and Drug Administration denied the company's 501(K) application for permission to...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!